IP Library Granted Patent US 9,470,697
Granted Patent B2
US 9,470,697 · App. 14/495,260 · Granted Oct 18, 2016

Methods for detecting risk of fatal prostate cancer using serum calcium

Inventors: Gary G. Schwartz (Winston-Salem, NC); Halcyon G. Skinner (Middleton, WI)
Assignee: Wake Forest University Health Services
G01N33/84G01N27/00G01N33/57434G01J3/42G01J3/46G01N33/574
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,470,697
App. No.
14/495,260
Granted
Oct 18, 2016
Kind
B2
Abstract

A method of screening for increased risk of fatal prostate cancer in a subject comprises providing a blood sample collected from the subject, and then detecting the presence or absence of an increased level of serum calcium in the sample. An increased level of serum calcium indicates the subject is at increased risk of fatal prostate cancer.

Claims (7)

1. A method of screening for increased risk of developing fatal prostate cancer in a human male subject in need thereof and treating said prostate cancer, comprising:

providing a blood sample collected from said subject; and

detecting the presence or absence of an increased level of ionized serum calcium in said sample by contacting said sample to an ion-selective electrode; and then potentiometrically measuring ionized calcium in said sample through said electrode, an increased level of greater than 1.2 mmol/L ionized serum calcium indicating said subject is at increased risk of developing fatal prostate cancer, and wherein upon detecting the presence of said increased level greater than 1.2 mmol/L, the method further comprises treating said prostate cancer with surgery, radiation therapy or combinations thereof.

2. The method of claim 1 , wherein said blood sample comprises whole blood, blood plasma, or blood serum.

3. The method of claim 1 , wherein said providing step comprises collecting a blood sample from said subject.

4. The method of claim 1 , wherein said providing step comprises at least partially purifying said blood sample.

5. The method of claim 1 , wherein said detecting step is a quantitative detecting step.

Assignments (1)
CONFIRMATORY LICENSE Recorded May 16, 2018
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046172/0798 →
Continuity (3)
Division 12644209 · Dec 22, 2009
Provisional Application 61141068 · Dec 29, 2008
Related Publication 20150010934A1 · Jan 8, 2015